🇺🇸 FDA
Patent

US 8415294

Cyclodepsipeptides with antineoplastic activity and methods of using to inhibit cancer and microbial growth

granted A61KA61K38/15A61P

Quick answer

US patent 8415294 (Cyclodepsipeptides with antineoplastic activity and methods of using to inhibit cancer and microbial growth) held by THE ARIZONA BOARD OF REGENTS expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE ARIZONA BOARD OF REGENTS
Grant date
Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/15, A61P, A61P31/00, A61P35/00